<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="47027">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02069327</url>
  </required_header>
  <id_info>
    <org_study_id>Fat Emboli</org_study_id>
    <nct_id>NCT02069327</nct_id>
  </id_info>
  <brief_title>The Role of Fat Emboli in the Trauma Inflammatory Response</brief_title>
  <official_title>The Role of Fat Emboli in the Trauma Inflammatory Response</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poudre Valley Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Colorado State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Poudre Valley Health System</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study designed to investigate the role of fat emboli in patients
      who are undergoing a tibial or femoral fracture procedure in the operating room. The purpose
      of this study is to obtain samples of bone marrow and blood during tibial or femoral
      fracture procedures to understand the inflammatory response.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bone marrow is routinely removed during a tibial or femoral fracture procedure; researchers
      will take samples for this study from bone marrow that has already been removed as part of
      this procedure.  No additional marrow samples will be taken as part of this research study.
      Also, researchers will collect blood (about 4 teaspoons) for testing inflammatory response
      and coagulation.   Researchers may need to insert an additional line to collect your blood.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2012</start_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Inflammatory Response</measure>
    <time_frame>One day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Samples will be tested using proteomic and metabolomic assays from samples of bone marrow reamed during intramedullary (IM) femoral nailing.
Blood samples drawn at the time of IM nailing will be tested to determine if clinically relevant amounts of marrow containing these inflammatory mediators are released into the bloodstream.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Femoral Fracture</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Bone marrow Blood specimen (~4 teaspoons)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing a tibial or femoral fracture procedure in the operating room.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing a tibial or femoral fracture procedure in the operating room.

        Exclusion Criteria:

          -  n/a
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julie Dunn, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Poudre Valley Health System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Center of the Rockies</name>
      <address>
        <city>Loveland</city>
        <state>Colorado</state>
        <zip>80538</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Jaskowiak, BS</last_name>
      <phone>970-624-1688</phone>
      <email>adam.jaskowiak@uchealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Katie Corey, RN</last_name>
      <phone>970-624-5295</phone>
      <email>katherine.corey@uchealth.org</email>
    </contact_backup>
    <investigator>
      <last_name>Julie Dunn, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 19, 2014</lastchanged_date>
  <firstreceived_date>February 3, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Poudre Valley Health System</investigator_affiliation>
    <investigator_full_name>Julie Dunn, M.D.</investigator_full_name>
    <investigator_title>Trauma Research Director / Trauma Surgeon</investigator_title>
  </responsible_party>
  <keyword>Femur</keyword>
  <keyword>Fat</keyword>
  <keyword>Emboli</keyword>
  <keyword>Bone</keyword>
  <keyword>Marrow</keyword>
  <keyword>proteomic</keyword>
  <keyword>proteomics</keyword>
  <keyword>metabolomics</keyword>
  <keyword>metabolomic</keyword>
  <keyword>inflammatory</keyword>
  <keyword>cytokine</keyword>
  <keyword>chemokine</keyword>
  <keyword>anaphlylatoxin</keyword>
  <keyword>Thromboelastography</keyword>
  <keyword>Medical Center of the Rockies</keyword>
  <keyword>Fat Embolism Syndrome</keyword>
  <keyword>Injury</keyword>
  <keyword>Fracture</keyword>
  <keyword>Metabolite</keyword>
  <keyword>MCR</keyword>
  <keyword>TEG</keyword>
  <keyword>FES</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Embolism, Fat</mesh_term>
    <mesh_term>Femoral Fractures</mesh_term>
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
